Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-12 08:27 am Unchanged | 13G | ADVAXIS INC PAR $0.001 ADXS | Schindel Yair Chaim | 560,602 1.31% | 0 (Unchanged) | View |
2024-01-03 08:52 am Unchanged | 13G | SEER INC SEER | Schindel Yair Chaim | 4,923,196 7.71% | 0 (Unchanged) | View |
2024-01-03 08:50 am Purchase | 13G | AKOYA BIOSCIENCES INC AKYA | Schindel Yair Chaim | 3,077,195 6.27% | 158,756 (+5.44%) | View |
2024-01-03 08:50 am Purchase | 13G | SERA PROGNOSTICS INC SERA | Schindel Yair Chaim | 2,978,511 9.5% | 1,060,000 (+55.25%) | View |
2023-10-23 06:45 am Unchanged | 13G | ADVAXIS INC PAR $0.001 ADXS | Schindel Yair Chaim | 560,602 5.21% | 0 (Unchanged) | View |
2023-06-13 07:18 am Purchase | 13G | AKOYA BIOSCIENCES INC AKYA | Schindel Yair Chaim | 2,918,439 6.03% | 2,918,439 (New Position) | View |
2023-05-18 11:23 am Purchase | 13D | SOPHIA GENETICS SA SHS SOPH | Schindel Yair Chaim | 4,933,205 7.68% | 1,722,338 (+53.64%) | View |
2023-01-30 06:01 am Purchase | 13G | ADVAXIS INC PAR $0.001 ADXS | Schindel Yair Chaim | 560,602 12.2% | 560,602 (New Position) | View |
2023-01-23 4:29 pm Sale | 13G | AYALA PHARMACEUTICALS INC AYLA | Schindel Yair Chaim | 0 0% | -2,991,473 (Position Closed) | View |
2023-01-10 5:21 pm Unchanged | 13D | VIRACTA THERAPEUTICS INC VIRX | Schindel Yair Chaim | 7,392,237 19.35% | 0 (Unchanged) | View |
2023-01-10 4:35 pm Unchanged | 13D | VIRACTA THERAPEUTICS INC VIRX | Schindel Yair Chaim | 7,392,237 19.35% | 0 (Unchanged) | View |
2023-01-10 4:30 pm Purchase | 13D | SOPHIA GENETICS SA SHS SOPH | Schindel Yair Chaim | 3,210,867 5% | 3,210,867 (New Position) | View |
2023-01-09 06:51 am Unchanged | 13G | AYALA PHARMACEUTICALS INC AYLA | Schindel Yair Chaim | 2,991,473 20.18% | 0 (Unchanged) | View |
2023-01-09 06:47 am Unchanged | 13G | SERA PROGNOSTICS INC SERA | Schindel Yair Chaim | 1,918,511 6.19% | 0 (Unchanged) | View |
2023-01-09 06:43 am Unchanged | 13G | SEER INC SEER | Schindel Yair Chaim | 4,923,196 7.86% | 0 (Unchanged) | View |
2022-01-24 06:12 am Purchase | 13G | SERA PROGNOSTICS INC SERA | Schindel Yair Chaim | 1,918,511 6.2% | 1,918,511 (New Position) | View |
2022-01-24 06:10 am Unchanged | 13G | AYALA PHARMACEUTICALS INC AYLA | Schindel Yair Chaim | 2,991,473 21.47% | 0 (Unchanged) | View |
2022-01-24 06:06 am Sale | 13G | SEER INC SEER | Schindel Yair Chaim | 4,923,196 8% | -1,000,000 (-16.88%) | View |
2021-03-02 06:14 am Unchanged | 13D | VIRACTA THERAPEUTICS INC VIRX | Schindel Yair Chaim | 7,392,237 19.98% | 0 (Unchanged) | View |
2021-03-01 06:06 am Purchase | 13D | VIRACTA THERAPEUTICS INC VIRX | Schindel Yair Chaim | 7,392,237 19.98% | 7,392,237 (New Position) | View |